The chemist alleges that he was left off of a patent for cortistatin A derivatives. Merck licensed the patent from Harvard for $20M.
Let’s see how this shakes out.
http://cen.acs.org/articles/95/web/2017/05/Researcher-sues-Harvard-for-drug-royalties.html
